- 1. *Pressure (Partial)
- (UMLS (HL7) C0030604) =Natural Phenomenon or Process ;
=Kind of quantity;
| - 51. PRECORDIAL PAIN
- (UMLS (ICD9CM) C0232286) =Sign or Symptom
|
- 2. 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate
- [A synthetic glucocorticoid receptor agonist that mimics the metabolic, anti-inflammatory, and immunosuppressive activity of the natural glucocorticoids. Amcinonide interacts with specific corticosteroid receptors and was internalized, which leads to binding of DNA and modification of gene expression. This results in synthesis of anti-inflammatory mediators while inhibiting synthesis of inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are achieved. ( NCI )] (UMLS (NCI) C0051556) =Steroid; Pharmacologic Substance =(11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;
[DE200] ANTI-INFLAMMATORY, TOPICAL =AMCINONIDE 0.1 % | - 52. Precortisyl
- (UMLS (NCI) C0591991) =Steroid; Pharmacologic Substance ;
|
- 3. pre mRNA
- [newly transcribed RNA fully complementary to the DNA sequence of structural genes; this component of the spliceosome and hnRNA is spliced, 5' capped, 3' polyadenylated, transported to the cytoplasm as mature mRNA, and translated. ( CSP )] (UMLS (CSP) C0026661) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =heterogeneous nuclear RNA;
spliceosome | - 53. Precose
- (UMLS (NCI) C0591572) =Carbohydrate; Pharmacologic Substance ;
|
- 4. Pre-Admit Test Indicator
- (UMLS (HL7) C1550372) =Qualitative Concept =HL7 Vocabulary Version 2.5;
| - 54. Precursor B Lymphoblastic Leukemia/Lymphoma
- [A neoplasm of lymphoblasts committed to the B-cell lineage, typically composed of small to medium-sized blast cells. When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called precursor B lymphoblastic leukemia (B-cell acute lymphoblastic leukemia). When it involves nodal or extranodal sites, it is called B lymphoblastic lymphoma. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0862030) Precursor B-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 5. Pre-authenticated
- [A completion status in which a document is transcribed but not authenticated. ( HL7V3.0 )] (UMLS (HL7) C1548389) =Idea or Concept =Document completion status;
DocumentCompletion | - 55. Precursor B-Lymphoblastic Lymphoma
- [An uncommon type of lymphoma. It constitutes approximately 10% of cases of lymphoblastic lymphoma. Approximately 75% of cases reported in a literature review were less than 18 years of age. The most commonly affected sites are the skin, bone, soft tissue, and lymph nodes. It has a high remission rate with a median survival of approximately 60 months. (WHO, 2001) ( NCI )] (UMLS (NCI) C0855146) =Neoplastic Process
|
- 6. Pre-B Acute Lymphoblastic Leukemia
- (UMLS (NCI) C1292769) =Neoplastic Process
| - 56. Precursor B-Lymphoblastic Lymphoma Refractory
- [Precursor B-lymphoblastic lymphoma resistant to treatment ( NCI )] (UMLS (NCI) C0855148) Refractory Precursor B-Lymphoblastic Lymphoma;
=Neoplastic Process |
- 7. Pre-B Lymphocyte
- [Cells from the stage of B LYMPHOCYTE development where B CELL HEAVY CHAIN GENE REARRANGEMENT is completed. The pre-B cell stage is preceded by the pro-B cell stage. ( MSH )] (UMLS (NCI) C0312738) =Cell ;
| - 57. Precursor B-Lymphoblastic Lymphoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).- 2003 ( NCI )] (UMLS (NCI) C0855149) Stage I Precursor B-Lymphoblastic Lymphoma;
=Neoplastic Process |
- 8. Pre-Dilution
- [The dilution of the specimen made prior to being loaded onto analytical equipment ( HL7V3.0 )] (UMLS (HL7) C1551349) =Idea or Concept =ActSpecObsDilutionCode;
| - 58. Precursor B-Lymphoblastic Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0862039) Stage II Precursor B-Lymphoblastic Lymphoma;
=Neoplastic Process |
- 9. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension
- [ ] (UMLS (ICD9CM) C0156679) =Disease or Syndrome
| - 59. Precursor B-Lymphoblastic Lymphoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0855150) Stage III Precursor B-Lymphoblastic Lymphoma;
=Neoplastic Process |
- 10. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, antepartum
- [ ] (UMLS (ICD9CM) C0156683) =Disease or Syndrome
| - 60. Precursor B-Lymphoblastic Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855151) Stage IV Precursor B-Lymphoblastic Lymphoma;
=Neoplastic Process |
- 11. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156680) =Disease or Syndrome
| - 61. Precursor Lymphoblastic Leukemia/Lymphoma
- [A neoplasm of immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage. Neoplasms involving the bone marrow and the peripheral blood are called precursor lymphoblastic leukemias or acute lymphoblastic leukemias. Neoplasms involving primarily lymph nodes or extranodal sites are called lymphoblastic lymphomas. — 2003 ( NCI )] (UMLS (NCI) C1335469) Precursor Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process ;
|
- 12. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, postpartum
- [ ] (UMLS (ICD9CM) C0156684) =Disease or Syndrome
| - 62. Precursor T Lymphoblastic Leukemia/Lymphoma
- [A neoplasm of lymphoblasts committed to the T-cell lineage, typically composed of small to medium-sized blast cells. When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is precursor T lymphoblastic leukemia (T-cell acute lymphoblastic leukemia). When it involves nodal or extranodal sites it is T- lymphoblastic lymphoma. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0854857) Precursor T Lymphoblastic Lymphoma/Leukemia;
Precursor T-Lymphoblastic Lymphoma/Leukemia =Neoplastic Process |
- 13. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, with delivery
- [ ] (UMLS (ICD9CM) C0156681) =Disease or Syndrome
| - 63. Precursor T Lymphoblastic Lymphoma
- [The most frequent type of lymphoblastic lymphoma. It comprises approximately 85-90% of cases. It is more frequently seen in adolescent males. It frequently presents with a mass lesion in the mediastinum. Pleural effusions are common. (WHO, 2001) ( NCI )] (UMLS (NCI) C1292758) Precursor T-Cell Lymphoblastic Lymphoma;
Precursor T-Lymphoblastic Lymphoma =Neoplastic Process |
- 14. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0156682) =Disease or Syndrome
| - 64. Precursor T Lymphoblastic Lymphoma/Leukemia Refractory
- [Precursor T-lymphoblastic lymphoma/leukemia resistant to treatment ( NCI )] (UMLS (NCI) C0854859) Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 15. Pre-Malignant Skin Epithelial Lesion
- (UMLS (NCI) C1335463) =Neoplastic Process ;
| - 65. Precursor T-Lymphoblastic Lymphoma/Leukemia Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (Rare in Hodgkin lymphoma). - 2003 ( NCI )] (UMLS (NCI) C0854860) Stage I Precursor T-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 16. pre-miRNA
- [Precursors to miRNA generated from pri-miRNA. They are exported from the nucleus where they are further processed by Dicer RNase to generate mature miRNA. ( MSH )] (UMLS (NCI) C1337053) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 66. Precursor T-Lymphoblastic Lymphoma/Leukemia Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in a with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0854861) Stage II Precursor T-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 17. Pre-Par
- (UMLS (NCI) C0043440) =Organic Chemical; Pharmacologic Substance
| - 67. Precursor T-Lymphoblastic Lymphoma/Leukemia Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0854862) Stage III Precursor T-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 18. pre-RC
- [The Origin Recognition Complex (ORC) in eukaryotic cells selects genomic sites where pre-replication complexes (pre-RCs) can be assembled. Subsequent activation of these pre-RCs results in bi-directional DNA replication that originates at or close to the ORC DNA binding sites. (From PubMed 12801628) ( NCI )] (UMLS (NCI) C1335464) Pre-Replication Complex =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 68. Precursor T-Lymphoblastic Lymphoma/Leukemia Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, or nodular involvement of the lungs(s). - 2003 ( NCI )] (UMLS (NCI) C0854864) Stage IV Precursor T-Lymphoblastic Lymphoma/Leukemia;
=Neoplastic Process |
- 19. preadmission counseling
- [counseling given to individuals being admitted to the hospital to prepare them for the visit. ( CSP )] (UMLS (CSP) C0597278) =Health Care Activity ;
=counseling;
preadmission patient care | - 69. PRED/TG/VCR
- (UMLS (NCI) C0281679) =Therapeutic or Preventive Procedure
|
- 20. preadmission patient care
- [services or procedures, such as laboratory tests and x-rays, performed on individuals being admitted to the hospital. ( CSP )] (UMLS (CSP) C0597279) =Health Care Activity ;
=Patient Care;
=preadmission counseling;
| - 70. PRED/VCR
- (UMLS (NCI) C0278972) =Therapeutic or Preventive Procedure
|
- 21. Preadmit
- (UMLS (HL7) C0694624) =Idea or Concept =Patient Class;
| - 71. Predate
- (UMLS (NCI) C0699540) =Steroid; Pharmacologic Substance
|
- 22. preadolescence
- [ ] (UMLS (CSP) C0598880) =Age Group ;
| - 72. predation
- [instinctual behavior pattern in which food is obtained by killing and consuming other animals. ( CSP )] (UMLS (CSP) C0032942) =Social Behavior =ethology;
|
- 23. Preamendment
- (UMLS (HL7) C1548596) =Idea or Concept =Marketing basis;
| - 73. prediabetic state
- [state of latent impairment of carbohydrate metabolism in which the criteria for diabetes mellitus are not all satisfied; sometimes controllable by diet alone; called also impaired glucose tolerance and impaired fasting glucose. ( CSP )] (UMLS (CSP) C0362046) =Disease or Syndrome ;
=Diabete mellito;
|
- 24. Preauricular
- (UMLS (HL7) C1550296) =Body Part, Organ, or Organ Component =Body Part;
| - 74. Predicted
- [An extrapolation of given data into the future. ( NCI )] (UMLS (NCI) C0681842) =Idea or Concept ;
|
- 25. PREAURICULAR CYST
- [ ] (UMLS (ICD9CM) C0158599) =Disease or Syndrome ;
| - 75. predictive factor
- [(pre-DIK-tiv) A situation or condition that may increase a person's risk of developing a certain disease or disorder. ( NCI )] (UMLS (NCI) C0683956) =Intellectual Product ;
|
- 26. Preauricular sinus or fistula
- [ ] (UMLS (ICD9CM) C0158598) =Disease or Syndrome ;
| - 76. Predisposition
- [The constitutional or inborn state disposing to a disease, group of diseases, or metabolic or structural anomaly. ( NCI )] (UMLS (NCI) C0220898) =Organism Attribute
|
- 27. prebiotic evolution
- [ ] (UMLS (CSP) C0597986) =Functional Concept ;
| - 77. Prednicarbate
- [A synthetic non-halogenated double-ester derivative of the corticosteroid prednisolone with anti-inflammatory, antipruritic and vasoconstrictive properties. Following skin permeation, prednicarbate enters cells and binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of pro-inflammatory cytokine production by increasing the expression of lipocortins. These block phospholipase A-dependent release of arachidonic acid thereby inhibiting prostaglandin synthesis. This agent also decreases the number of circulating lymphocytes by suppression of the production of vasodilators such as prostacyclin and nitric oxide. ( NCI )] (UMLS (NCI) C0071836) =Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;
[DE200] ANTI-INFLAMMATORY, TOPICAL =PREDNICARBATE 0.1 % |
- 28. Precancerous Atypia
- (UMLS (NCI) C1335465) Premalignant Atypia =Finding ;
| - 78. PREDNISOLONE ACETATE
- [The acetate salt form of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. As a glucocorticoid receptor agonist, prednisolone acetate binds to specific intracellular glucocorticoid receptors, and causes the ligand-receptor complex to be translocated to the nucleus where it initiates the transcription of glucocorticoid-responsive genes such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations. ( NCI )] (UMLS (NCI) C0071839) =Steroid; Pharmacologic Substance =(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;
[OP300] ANTI-INFLAMMATORIES, TOPICAL OPHTHALMIC =PREDNISOLONE ACETATE POWDER (GM);
PREDNISOLONE ACETATE 5 MG;
PREDNISOLONE ACETATE 1 %;
PREDNISOLONE ACETATE 25 MG/ML;
PREDNISOLONE ACETATE 0.6 %;
PREDNISOLONE ACETATE 0.2 %;
PREDNISOLONE ACETATE 0.12 %;
PREDNISOLONE ACETATE 0.125 %;
PREDNISOLONE ACETATE 100 MG/ML;
PREDNISOLONE ACETATE 40 MG/ML;
PREDNISOLONE ACETATE 0.5 %;
PREDNISOLONE ACETATE 0.25 %;
PREDNISOLONE ACETATE 80 MG;
PREDNISOLONE ACETATE 50 MG/ML;
|
- 29. Precancerous Condition
- [A pathological process which shows signs that they can become cancerous. Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia. ( NCI )] (UMLS (NCI) C0032927) =Neoplastic Process =KASVAIMET;
=Cervix Dysplasia;
erythroplakia;
Keratotic Plaque;
AIL;
Dysmyelopoietic Syndrome;
Angioma Pigmentosum Atrophicum;
Lymphomatoid Papulosis | - 79. Prednisolone Sodium Metasulphobenzoate
- [A poorly adsorbed analog of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, prednisolone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI) ( NCI )] (UMLS (NCI) C0889299) =Steroid; Pharmacologic Substance
|
- 30. Precancerous Condition by Site
- (UMLS (NCI) C1335466) Premalignant Condition by Site =Disease or Syndrome ;
| - 80. Prednisolone sodium succinate
- [The sodium succinate salt form of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, prednisolone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI) ( NCI )] (UMLS (NCI) C0138274) =Steroid; Pharmacologic Substance
|
- 31. precancerous dermatitis
- [A skin disease marked by scaly or thickened patches on the skin, and often caused by prolonged exposure to arsenic. The patches often occur on sunexposed areas of the skin and in older white men. These patches may become malignant (cancerous). ( NCI )] (UMLS (NCI) C1335467) =Disease or Syndrome ;
| - 81. Prednisolone Tebutate
- (UMLS (NCI) C0071844) =Steroid; Pharmacologic Substance =(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;
=PREDNISOLONE TEBUTATE 20 MG/ML |
- 32. Precancerous Melanosis
- (UMLS (NCI) C0334435) =Neoplastic Process
| - 82. Prednisone/Thalidomide
- (UMLS (NCI) C0935735) =Therapeutic or Preventive Procedure
|
- 33. Precancerous Polyp
- [Growths that protrude from a mucous membrane. Precancerous polyps may (or are likely to) become cancer. ( NCI )] (UMLS (NCI) C1335468) precancerous polyps;
=Neoplastic Process ;
| - 83. Prednisone/UCN-01
- (UMLS (NCI) C1327774) =Therapeutic or Preventive Procedure ;
|
- 34. Precaution Code
- (UMLS (HL7) C1547814) =Intellectual Product =HL7 Vocabulary Version 2.5;
=On IV;
Aggressive;
Confused;
Deaf;
_No-code_ (i.e. Do not resuscitate);
Other;
Paraplegic;
Unknown;
Blind;
| - 84. predoctoral investigator
- [used to indicate the investigator's career development stage; not mechanism based, however most frequently used for T, F, and K mechanisms. ( CSP )] (UMLS (CSP) C0920371) =Professional or Occupational Group ;
=Education;
tag term |
- 35. precedence effect
- [ ] (UMLS (CSP) C0599694) =Mental Process ;
| - 85. Predominant disturbance of consciousness
- [ ] (UMLS (ICD9CM) C0154579) =Mental or Behavioral Dysfunction
|
- 36. Precentral Gyrus
- (UMLS (NCI) C0152299) =Body Part, Organ, or Organ Component
| - 86. Predominant disturbance of emotions
- [ ] (UMLS (ICD9CM) C0154578) =Mental or Behavioral Dysfunction
|
- 37. Precentral Sulcus
- (UMLS (NCI) C0228201) =Body Space or Junction
| - 87. Predominant psychomotor disturbance
- [ ] (UMLS (ICD9CM) C0154580) =Mental or Behavioral Dysfunction
|
- 38. precinct
- [A subsection of a municipality ( HL7V3.0 )] (UMLS (HL7) C1555559) =Idea or Concept =AddressPartType;
| - 88. preexcitation syndrome
- [A group of conditions in which HEART VENTRICLE activation by the atrial impulse is faster than the normal impulse conduction from the SINOATRIAL NODE. In these pre-excitation syndromes, atrial impulses often bypass the ATRIOVENTRICULAR NODE delay and travel via accessory pathways connecting the atrium directly to the BUNDLE OF HIS. ( MSH )] (UMLS (CSP) C0032915) =Disease or Syndrome =arrhythmia;
=LOWN-GANONG-LEVINE SYND;
Pre-Excitation, Mahaim-Type;
Wolff Parkinson White syndrome |
- 39. PRECIPITATE DEL AFF NB
- [ ] (UMLS (ICD9CM) C0158845) =Disease or Syndrome
| - 89. Preexisting Condition
- [A health condition or medical problem that was diagnosed or treated before a specific date. ( NCI )] (UMLS (NCI) C0521987) =Finding
|
- 40. Precipitate labor
- [ ] (UMLS (ICD9CM) C0473472) =Disease or Syndrome
| - 90. Preference
- (UMLS (HL7) C1549513) =Idea or Concept =Diet Code Specification Type;
|
- 41. Precipitate labor, antepartum
- [ ] (UMLS (ICD9CM) C0157250) =Disease or Syndrome
| - 91. Preference
- [partiality, favor, priority or advantage granted to one over another; a liking for a person, place, thing, behavior, action, etc.; closely related to CHOICE and BIAS. ( CSP )] (UMLS (NCI) C0558295) =Idea or Concept =attitude;
|
- 42. Precipitate labor, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0157248) =Disease or Syndrome
| - 92. Preferred
- (UMLS (HL7) C1548789) =Qualitative Concept =Specimen Appropriateness;
|
- 43. Precipitate labor, with delivery
- [ ] (UMLS (ICD9CM) C0157249) =Disease or Syndrome
| - 93. preferred accommodation invoice
- [HealthCare facility preferred accommodation invoice. ( HL7V3.0 )] (UMLS (HL7) C1555658) =Intellectual Product =ActInvoiceRootGroupCode;
|
- 44. precipitation
- [substance in solution settling down in solid particles. ( CSP )] (UMLS (CSP) C0032931) =Natural Phenomenon or Process =phase change;
| - 94. Preferred method of contact
- (UMLS (HL7) C1547603) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Beeper Number;
Cellular Phone Number;
E-Mail Address (for backward compatibility);
FAX;
Home Phone Number;
Office Phone Number;
|
- 45. precipitin
- [Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen. ( MSH )] (UMLS (CSP) C0032936) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 95. Preferred Provider Organization
- [A group of physicians and/or hospitals who contract with an employer to provide services to their employees. In a PPO, the patient may got to the physician of his/her choice, even if that physician does not participate in the PPO, but the patient receives care at a lower benefit level.Source: "Glossary of terms used in managed care" Developed by the Managed Care Assembly (MCA) of Medical Group Management Association (MGMA), MGM Journal, September/ October 1995, p. 62 ( HL7V3.0 )] (UMLS (HL7) C0032956) =Health Care Related Organization =Managed Care Organization;
|
- 46. Precipitin
- [Precipitation, Precipitin ( HL7V3.0 )] (UMLS (HL7) C1553169) =Laboratory Procedure =ObservationMethod;
| - 96. prefix
- [An affix occurring at or before the beginning of a word or name. ( NCI )] (UMLS (HL7) C1550720) =Idea or Concept =EntityNamePartType;
|
- 47. Precision
- (UMLS (HL7) C1547902) =Temporal Concept =HL7 Vocabulary Version 2.5;
=h;
m;
second;
day;
month;
year;
| - 97. Prefix Family Middle Given Suffix
- (UMLS (HL7) C1547432) =Idea or Concept =Name assembly order;
|
- 48. precocious puberty
- [unusually early sexual maturity. ( CSP )] (UMLS (CSP) C0034013) =Disease or Syndrome =Endocrine Disease;
gonad disorder;
sex development disorder;
| - 98. Prefix Given Middle Family Suffix
- (UMLS (HL7) C1547433) =Idea or Concept =Name assembly order;
|
- 49. Precocious sexual development and puberty, not elsewhere classified
- [ ] (UMLS (ICD9CM) C0869515) SEXUAL PRECOCITY NEC;
=Disease or Syndrome ;
| - 99. prefrontal cortex
- [The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the mediodorsal nucleus of the thalamus. The prefrontal cortex receives afferent fibers from numerous structures of the diencephalon, mesencephalon, and limbic system as well as cortical afferents of visual, auditory, and somatic origin. ( MSH )] (UMLS (CSP) C0162783) =Body Part, Organ, or Organ Component ;
|
- 50. precommissural setum
- [ ] (UMLS (CSP) C0598033) =Body Part, Organ, or Organ Component ;
| - 100. prefrontal lobe
- [ ] (UMLS (CSP) C0920637) =Body Part, Organ, or Organ Component ;
|
home
